Skip to main content
CHRS logo

CHRS · Coherus Oncology, Inc. · Documents

Track CHRS — free
$0.37 -0.02 (-4.47%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$57.15M
Shares
154.54M
Volume · Nov 20 2.52M Avg daily vol (3M) 1.8M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025
Mar 17
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $266.96M ▲ 3.8% Net income $28.51M Diluted EPS $0.25
2024
Mar 15
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $257.24M ▲ 21.9% Net loss $237.89M Diluted EPS -$2.53
Showing 51–100 of 205 documents
Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 150 filings 120 filers Visit website Investor relations